Alexesia S. Williams, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 48 Charleston Way, Hattiesburg, MS 39402 Phone: 601-329-9580 |
Sandreal A Pounds, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 115 Thornhill Dr Ste A, Hattiesburg, MS 39402 Phone: 601-653-7536 Fax: 769-500-1661 |
Karen Holmes, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 41 Bonhomie Rd, Hattiesburg, MS 39401 Phone: 601-450-0431 Fax: 601-450-0433 |
Lauren Aultman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 103 S 19th Ave, Hattiesburg, MS 39401 Phone: 601-544-4601 Fax: 601-582-1607 |
Lawanda Allen, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 12 Bridgefield Cir, Hattiesburg, MS 39402 Phone: 601-336-9450 |
Deborah Lefler, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 231 Methodist Blvd, Hattiesburg, MS 39402 Phone: 601-268-8088 |
News Archive
The White House criticized the findings of a report by a conservative economist who serves as a trustee overseeing Medicare and Social Security finances, saying they represented a partisan analysis.
Stephanie C. Eken, M.D., F.A.A.P., a regional medical director with Rogers Behavioral Health System, will address the issue of childhood anxiety at the 2015 National Association of Therapeutic Schools and Programs (NATSAP) conference on February 6 in Nashville, TN.
NanoImaging Services, Inc., announced today that it has received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health through the National Center for Research Resources to develop new methods for quantitative characterization of nanoparticle morphology and aggregation state using transmission electron microscopy. The grant provides approximately $200,000 in research and development funds for a Phase I study.
A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has received a $5.6 million grant award from the United States Food and Drug Administration (FDA) to use its Organs-on-Chips technology for a novel application of keen interest to national security and health officials: to test human physiological responses to radiation, and to evaluate drugs designed to counter those effects.
Mylan N.V., today announced the U.S. launch of Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg / 0.05 mg. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Zovia® 1/50E-28 Tablets (Watson).
› Verified 4 days ago